Two new drugs will soon be available to target little-known forms of high cholesterol, which are driven by our genes and ...

Eli Lilly's muvalaplin Phase 2 trial showed significant Lp(a) reduction, meeting primary and secondary endpoints with ...

Eli Lilly LLY announced that its investigational oral, once-daily cholesterol-lowering drug muvalaplin reduced lipoprotein(a) ...

Dr Eric Berg DC is a ketosis and intermittent fasting expert, and he has shared the many benefits of turmeric, as well as how ...

The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin, at the American Heart Association Scientific ...

Dr Eric Berg DC, who is known as The Knowledge Doc, has shared the 'amazing benefits' of taking half a teaspoon of a ...

Alcohol can change how your body breaks down and absorbs medications, causing adverse reactions, and even overdose. Here are ...

Lilly’s muvalaplin is the first oral drug to show positive Phase II findings for Lp(a) reduction, eliciting up to an 86% drop ...

Unexplained fluctuations in cholesterol levels have been linked to dementia and cognitive decline in a recent study.

An experimental oral drug called muvalaplin shows promise in reducing the cholesterol linked to heart disease in a study.

Older adults with significant fluctuations in cholesterol levels are at increased risk for dementia and cognitive decline, ...

Eating plant-based foods that are rich in fiber and healthy fats through what’s long been known as the portfolio diet is one ...